Kelly Jared's Form 4 filing
Oncolytics Biotech Inc (ONCY) · filed Feb 13, 2026
- Accession no.
- 0001493152-26-006545
- Filed
- Feb 13, 2026
- Trade date
- Feb 11-12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $29.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kelly JaredCIK 0002103581 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Common Shares | PPurchaseAcquired | +5,600 | $0.84 | +$4,704 | 79,500 | Direct | |
| Feb 12, 2026 | Common Shares | PPurchaseAcquired | +29,500 | $0.84 | +$24,780 | 109,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.